Statements (75)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:legal_case
|
| gptkbp:age |
50 years and older
|
| gptkbp:aims_to |
reduce cardiovascular events
|
| gptkbp:approves |
institutional review boards
|
| gptkbp:completed |
gptkb:2015
|
| gptkbp:conducted |
gptkb:United_States
|
| gptkbp:contributed_to |
understanding of hypertension management
|
| gptkbp:ends_at |
lowering blood pressure reduces risk of heart failure
|
| gptkbp:established |
gptkb:NHLBI
|
| gptkbp:exhibited_at |
benefits of intensive blood pressure control
|
| gptkbp:focuses_on |
hypertension
|
| gptkbp:has_impact_on |
gptkb:healthcare_organization
long-term effects |
| gptkbp:has_influence_on |
future research directions
medical education curricula |
| https://www.w3.org/2000/01/rdf-schema#label |
The SPRINT Trial
|
| gptkbp:influenced |
hypertension treatment guidelines
|
| gptkbp:is_affected_by |
clinical decision making
patient education materials |
| gptkbp:is_analyzed_in |
cost-effectiveness
systematic reviews cardiovascular mortality |
| gptkbp:is_associated_with |
improved patient outcomes
|
| gptkbp:is_challenged_by |
alternative studies
|
| gptkbp:is_cited_in |
gptkb:hospital
numerous research articles |
| gptkbp:is_compared_to |
intensive treatment vs standard treatment
|
| gptkbp:is_considered |
landmark study
a model for future trials a pivotal trial |
| gptkbp:is_discussed_in |
gptkb:academic_journal
medical conferences health policy debates patient care discussions |
| gptkbp:is_evaluated_by |
peer review process
long-term benefits safety and efficacy clinical trials registries |
| gptkbp:is_part_of |
hypertension research
clinical trial networks larger research initiative evidence-based medicine discussions clinical research history hypertension management strategies |
| gptkbp:is_recognized_by |
medical community
|
| gptkbp:is_referenced_in |
gptkb:municipality
medical textbooks |
| gptkbp:is_related_to |
gptkb:ASCOT_trial
|
| gptkbp:is_supported_by |
grants
government funding patient advocacy groups |
| gptkbp:is_used_for |
a reference study
|
| gptkbp:launched |
gptkb:2010
|
| gptkbp:led_to |
gptkb:Dr._Paul_K._Whelton
new treatment protocols improved treatment adherence increased awareness of hypertension risks |
| gptkbp:measures |
systolic blood pressure
|
| gptkbp:participants |
gptkb:Company
over 9,000 |
| gptkbp:produced_by |
public interest
further research questions |
| gptkbp:provides |
insights into patient demographics
evidence for policy changes |
| gptkbp:provides_information_on |
quality of life
|
| gptkbp:published_by |
gptkb:New_England_Journal_of_Medicine
|
| gptkbp:receives_funding_from |
gptkb:healthcare_organization
|
| gptkbp:reports_to |
cognitive decline
|
| gptkbp:result |
gptkb:2015
|
| gptkbp:sponsor |
gptkb:Research_Institute
|
| gptkbp:uses |
randomized controlled trial design
|
| gptkbp:utilizes |
multiple sites
placebo-controlled methods |
| gptkbp:bfsParent |
gptkb:The_New_England_Journal_of_Medicine
|
| gptkbp:bfsLayer |
5
|